
Permanence Bio
We Protect the Genome
Permanence Bio is a biotech company in San Francisco, United States, founded in 2024. It has raised $35.0M across 2 rounds, most recently a $20.0M Series A in January 2026.
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- permanence.bio
- Total Funding
- $35.0M
- Last Round
- $20.0M Series AJan 2026
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 3 investors for this company. to use credits for reveals, or explore the API.
About
Permanence Bio creates medicines to shield DNA from damage associated with aging, disease, and cancer. It combines screening at scale with AI to find therapies, focusing its work on protection from DNA damage. Its research connects the search for therapies with the goal of addressing damage behind these conditions.
Funding History
Jan 2026
1 more funding event
- Pre-seed20241 investor
Funding: Pre-Seed through Series A. Amounts, valuations, and investors where available.
Investors
Companies in related industries

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/permanence-bio"><img src="https://indexed.vc/api/badge/company/permanence-bio" alt="Permanence Bio on Indexed.vc" width="260" height="76" /></a>

